VANGUARD GROUP INC - CASTLE BIOSCIENCES INC ownership

CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 126 filers reported holding CASTLE BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CASTLE BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$24,311,264
+24.1%
1,439,388
+0.8%
0.00%
Q2 2023$19,584,217
-38.6%
1,427,421
+1.7%
0.00%
-100.0%
Q1 2023$31,896,631
-2.7%
1,403,901
+0.8%
0.00%0.0%
Q4 2022$32,784,723
+0.5%
1,392,724
+11.4%
0.00%0.0%
Q3 2022$32,620,000
+22.7%
1,250,733
+3.3%
0.00%0.0%
Q2 2022$26,577,000
-49.6%
1,210,796
+2.9%
0.00%0.0%
Q1 2022$52,766,000
+5.8%
1,176,227
+1.2%
0.00%0.0%
Q4 2021$49,851,000
-35.7%
1,162,841
-0.3%
0.00%
-50.0%
Q3 2021$77,551,000
-6.2%
1,166,188
+3.5%
0.00%0.0%
Q2 2021$82,658,000
+18.9%
1,127,192
+11.0%
0.00%0.0%
Q1 2021$69,497,000
+11.2%
1,015,122
+9.1%
0.00%0.0%
Q4 2020$62,485,000
+85.7%
930,525
+42.3%
0.00%
+100.0%
Q3 2020$33,651,000
+64.8%
654,059
+20.7%
0.00%0.0%
Q2 2020$20,418,000
+212.1%
541,749
+146.8%
0.00%
Q1 2020$6,543,000
-5.1%
219,490
+9.5%
0.00%
Q4 2019$6,891,000
+237.3%
200,502
+77.6%
0.00%
Q3 2019$2,043,000112,9130.00%
Other shareholders
CASTLE BIOSCIENCES INC shareholders Q2 2020
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 33,626$567,94377.21%
Millrace Asset Group, Inc. 77,315$1,3061.61%
Granahan Investment Management 2,487,673$42,016,7971.50%
Parkman Healthcare Partners LLC 224,592$3,793,3590.70%
PERKINS CAPITAL MANAGEMENT INC 29,160$4930.49%
Capital Impact Advisors, LLC 16,554$279,5970.47%
Soleus Capital Management, L.P. 283,500$4,788,3150.44%
Portolan Capital Management 253,028$4,273,6430.40%
Numerai GP LLC 68,163$1,151,2730.38%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 946,620$15,988,4120.35%
View complete list of CASTLE BIOSCIENCES INC shareholders